Gulf International Bank UK Ltd Has $7,571,000 Position in Cardinal Health Inc. (CAH)
Gulf International Bank UK Ltd maintained its stake in shares of Cardinal Health Inc. (NYSE:CAH) during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 97,441 shares of the company’s stock at the end of the third quarter. Gulf International Bank UK Ltd’s holdings in Cardinal Health were worth $7,571,000 at the end of the most recent quarter.
Other hedge funds have also modified their holdings of the company. Forte Capital LLC ADV raised its stake in shares of Cardinal Health by 26.2% in the second quarter. Forte Capital LLC ADV now owns 8,520 shares of the company’s stock valued at $665,000 after buying an additional 1,770 shares in the last quarter. Benjamin F. Edwards & Company Inc. raised its stake in shares of Cardinal Health by 0.6% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 4,265 shares of the company’s stock valued at $333,000 after buying an additional 26 shares in the last quarter. Trust Co raised its stake in shares of Cardinal Health by 3.1% in the first quarter. Trust Co now owns 2,989 shares of the company’s stock valued at $245,000 after buying an additional 90 shares in the last quarter. Exxonmobil Investment Management Inc. TX raised its stake in shares of Cardinal Health by 5.2% in the second quarter. Exxonmobil Investment Management Inc. TX now owns 84,337 shares of the company’s stock valued at $6,579,000 after buying an additional 4,153 shares in the last quarter. Finally, DNB Asset Management AS raised its stake in shares of Cardinal Health by 3.1% in the second quarter. DNB Asset Management AS now owns 26,783 shares of the company’s stock valued at $2,089,000 after buying an additional 800 shares in the last quarter. Hedge funds and other institutional investors own 84.54% of the company’s stock.
Shares of Cardinal Health Inc. (NYSE:CAH) traded down 0.20% on Wednesday, reaching $70.85. 1,729,179 shares of the company were exchanged. Cardinal Health Inc. has a 52-week low of $62.70 and a 52-week high of $91.23. The company has a market capitalization of $22.68 billion, a P/E ratio of 17.15 and a beta of 0.73. The stock has a 50 day moving average of $71.75 and a 200-day moving average of $77.55.
Cardinal Health (NYSE:CAH) last posted its earnings results on Monday, October 31st. The company reported $1.24 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.03. The firm earned $32 billion during the quarter, compared to analysts’ expectations of $31.12 billion. Cardinal Health had a net margin of 1.08% and a return on equity of 25.20%. The company’s revenue was up 14.2% compared to the same quarter last year. During the same period in the previous year, the company earned $1.38 earnings per share. On average, analysts predict that Cardinal Health Inc. will post $5.47 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Sunday, January 15th. Shareholders of record on Tuesday, January 3rd will be paid a $0.4489 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 2.53%. The ex-dividend date of this dividend is Thursday, December 29th. Cardinal Health’s dividend payout ratio (DPR) is presently 43.58%.
TRADEMARK VIOLATION WARNING: This story was posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this story on another site, it was stolen and reposted in violation of US and international copyright & trademark legislation. The original version of this story can be viewed at https://www.thecerbatgem.com/2016/11/30/gulf-international-bank-uk-ltd-has-7571000-position-in-cardinal-health-inc-cah.html.
Several brokerages have recently commented on CAH. Citigroup Inc. increased their price objective on Cardinal Health from $87.00 to $93.00 and gave the company a “neutral” rating in a report on Wednesday, August 3rd. Deutsche Bank AG increased their price objective on Cardinal Health from $83.00 to $89.00 and gave the company a “hold” rating in a report on Thursday, August 4th. Leerink Swann reiterated a “buy” rating on shares of Cardinal Health in a report on Wednesday, August 3rd. Zacks Investment Research upgraded Cardinal Health from a “sell” rating to a “hold” rating in a research note on Monday, August 8th. Finally, Credit Suisse Group AG restated a “buy” rating and issued a $97.00 target price on shares of Cardinal Health in a research note on Tuesday, August 30th. Ten equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company’s stock. Cardinal Health presently has an average rating of “Buy” and an average price target of $91.62.
In other Cardinal Health news, Chairman George S. Barrett sold 217,995 shares of Cardinal Health stock in a transaction that occurred on Thursday, November 10th. The shares were sold at an average price of $71.29, for a total value of $15,540,863.55. Following the completion of the sale, the chairman now directly owns 682,226 shares in the company, valued at $48,635,891.54. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.94% of the stock is currently owned by company insiders.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.